Article
Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Clinical genetics - 1 Jul 2012
Sarafoglou K, Lorentz C P, Otten N, Oetting W S, Grebe S K G
Abstract excerpt
Newborn screening (NBS) identifies the majority of classical [salt-wasting (SW) and simple-virilizing (SV)] cases of congenital adrenal hyperplasia (CAH) due to 21α-hydroxylase (21α-OHase) during the first days of life. Diagnosis of classical CAH is confirmed by follow-up serum 17-hydroxyprogesterone and/or the adrenocorticotropin stimulation test; however, neither test definitively distinguishes between the...
Topics
- 17-alpha-Hydroxyprogesterone
- Adolescent
- Adrenal Hyperplasia, Congenital
- Adrenocorticotropic Hormone
- Adult
- Alleles
- Child
- Child, Preschool
- Female
- Fludrocortisone
- Genetic Association Studies
